Entecavir

BNF:

5.3.3

Status:

Red

Decision Date:

April 2016

Comments

RED: ^1,2,3 NICE TA153 for the treatment of chronic hepatitis B (August 2008).

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
• 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
• 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)

search again